Abstract
Various pharmacokinetic parameters (disposition half-life, total body clearance, renal clearance, hepatic clearance, volume of distribution, intrinsic clearance and volume of distribution of unbound drug) of sixβ-lactam antibiotics were compared in mouse, rat, rabbit, dog, monkey, and human. Two methods for prediction of the disposition of theβ-lactam antibiotics in humans by extrapolation of the animal data were evaluated. One was the Adolph-Dedrick approach, which can be used to predict clearances in humans from the relationship between intrinsic clearances and body weight in the other five species. The volume of distribution in humans was predicted from the relationship between the volume of distribution and serum unbound fraction in the five species. The other was the Boxenbaum approach, which can be used to predict the pharmacokinetic parameters of the sixβ-lactam antibiotics in humans by using the regression lines of log-log plots of intrinsic clearance and volume of distribution of unbound drug in a single species, in this case the monkey. The half-life calculated according to the latter method had a smaller absolute error than that calculated according to the former method, but the better method for extrapolation of animal data to humans seems to be the former method, which does not require a prioriinformation regarding structure-pharmacokinetic relationships among the antibiotics.
Similar content being viewed by others
References
L. B. Mellett. Comparative drug metabolism.Progr. Drug. Res. 13:136–169 (1969).
R. L. Dedrick, K. B. Bischoff, and D. S. Zaharko. Interpecies correlation of plasma concentration history of methotrexate.Cancer Chemother. Part 1,54:95–101 (1970).
R. L. Dedrick. Animal scale up.J. Pharmacokin. Biopharm. 1:435–461 (1973).
U. Klotz, K. H. Antonin, and P. R. Bieck. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig, and rat.J. Pharmacol. Exp. Ther. 199:67–73 (1976).
C. H. Walker. Species differences in microsomal monoxygenase activity and their relationship to biological half-lives.Drug Metab. Rev. 7:295–323 (1978).
C. H. Walker. Species variations in some hepatic microsomal enzymes that metabolize xenobiotics. In J. W. Bridges and L. F. Chasseaud (eds.),Progress in Drug Metabolism, Vol. 5, Wiley, London, 1980, Chap. 2, pp. 113–164.
R. L. Dedrick, D. D. Forester, J. N. Cannon, S. M. ElDareen, and L. B. Mellett. Pharmacokinetics of 1-β-D-arabino-furanosylcytosine (Ara-C) deamination in several species.Biochem. Pharmacol. 22:2405–2417 (1973).
N. Benowitz, R. P. Forsyth, K. L. Melmon, and M. Rowland. Lidocaine disposition kinetics in monkey and man I. Prediction by a perfusion model.Clin. Pharmacol. Ther. 16:87–98 (1974).
H. Harashima, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano. Analysis of non-linear tissue distribution of quinidine in rats by physiologically based pharmacokinetics and scale-up to humans.J. Pharmacokin. Biopharm. submitted for publication.
Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model.J. Pharmacokin. Biopharm. 11:577–593 (1983).
H. Boxenbaum. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance extrapolation of data to benzodiazepines and phenytoin.J. Pharmacokin. Biopharm. 8:165–176 (1980).
H. Boxenbaum. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.J. Pharmacokin. Biopharm. 10:201–227 (1982).
H. Boxenbaum. Comparative pharmacokinetics of benzodiazepines in dog and man.J. Pharmacokin. Biopharm. 10:411–426 (1982).
A. Tsuji, E. Miyamoto, T. Terasaki, T. Yamana. Physiological pharmacokinetics ofβ-lactam antibiotics: penicillin V distribution and elimination after intravenous administration in rats.J. Pharm. Pharmacol. 31:116–119 (1979).
D. S. Greene, R. Quintiliani, and C. H. Nightingale. Physiological perfusion model for cephalosporin antibiotics 1: model selection based on blood drug concentrations.J. Pharm. Sci. 67:191–196 (1978).
A. Tsuji. Quantitative structure-pharmacokinetic relationship of drugs. In Kozokasseisokankonwakai (eds.),Structure-Activity Relationship-Quantitative Approaches. The Applications to Drug Design and Model-of-Action Studies. Kagaku no Ryoiki Zokan, Vol. 136, Nankodo, Tokyo and Kyoto, 1982, Chap. 10, pp. 229–251.
E. F. Adolph. Quantitative relations in the physiological constitutions of mammals.Science 109:579–585 (1949).
M. Komiya, Y. Kikuchi, A. Tachibana, and K. Yano. Absorption, distribution, metabolism and excretion of cefotetan (YM-09330), a new broad spectrum cephamycin, in experimental animals.Chemotherapy 30:106–118 (1982).
M. Komiya, Y. Kikuchi, A. Tachibana, and K. Yano. Pharmacokinetics of new broadspectrum cephamycin, YM-09330, parentally administered to various experimental animals.Antimicrob. Agents Chemother. 20:176–183 (1981).
K. Nakagawa, M. Koyama, A. Tachibana, M. Komiya, Y. Kikuchi, and Y. Yano. Pharmacokinetics of cefotetan (YM-09330) in humans.Antimicrob. Agents Chemother. 22:935–941 (1982).
H. Shindo, K. Kawai, T. Maeda, I. Igarashi, M. Tajima, and S. Sugawara. Absorption, distribution, excretion and metabolism of a new cephamycin antibiotic, CS-1170, in various animal species.Chemotherapy 26(s-5):99–114 (1978).
I. Saikawa, T. Yasuda, Y. Watanabe, H. Taki, N. Matsubara, T. Hayashi, K. Matsunaga, and R. Takata. Absorption, tissue distribution and excretion of cefoperazone (T-1551).Chemotherapy 28(s-6):163–172 (1980).
C. M. Metzler, G. L. Elfring, and A. J. McEwen. A package of computer programs for pharmacokinetic modeling,biometrics 30:562–563 (1974).
T. Nakagawa, Y. Koyanagi, and H. Togawa. SALS, a computer program for statistical analysis with least squares fitting. Library program of the University of Tokyo Computer Center, Tokyo, Japan, 1978.
M. Gibaldi and D. Perrier.Drugs and Pharmaceutical Science, Vol. 1. Pharmacokinetics, 2nd ed. Marcel Dekker, New York, 1982, pp. 1–111.
B. Kemmerich, H. Lode, G. Belmega, T. Jendroschek, K. Borner, and P. Koeppe. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.Antimicrob. Agents Chemother. 23:429–434 (1983).
T. Yoshida, Y. Kimura, and Y. Tochino. Pharmacokinetics of 6059-S in experimental animals.Chemotherapy 28(s-7):194–206 (1980).
K. Sugeno, H. Okabe, H. Tanaka, and R. Norikura. Disposition of 6059-S in rats, dogs and monkeys.Chemotherapy 28(s-7):207–235 (1980).
K. Nakagawa, M. Koyama, H. Matsui, C. Ikeda, K. Yanao, N. Nakatsuru, K. Yoshinaga, and T. Noguchi. Pharmacokinetics of cefpiramide (SM-1652) administered intravenously to healthy volunteers.Chemotherapy 31(s-l):144–157 (1983).
H. Matsui, K. Yano, and T. Okuda. Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys.Antimicrob. Agents Chemother. 22:213–217 (1982).
H. Imasaki, Y. Enjoh, H. Matsui, R. Kawai, S. Kawamura, and T. Okuda. Absorption, distribution, metabolism and excretion of14C-cefpiramide (14C-SM-1652) in rats after parenteral administration.Chemotherapy 31(s-l):124–134 (1983).
G. Levy. Effect of plasma protein binding on renal clearance of drugs.J. Pharm. Sci. 69:482–483 (1980).
M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1:123–136 (1973).
K. J. Child and M. G. Dodds. Mechanism of urinary excretion of cephaloridine and its effect on renal function in animals.Br. J. Pharmacol. Chemother. 26:108–119 (1966).
G. R. Wilkinson and D. G. Shand. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).
L. Z. Benet and R. L. Galeazzi. Noncompartmental determination of the steady state volume of distribution.J. Pharm. Sci. 68:1071–1074 (1979).
O. Sugita, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano. ESect of sulphaphenazole on tolbutamide distribution in rabbit. Analysis of interspecies difference in tissue distribution of tolbutamide.J. Pharm. Sci. 73:631–634 (1984).
S. Øie and T. N. Tozer. Effect of altered plasma protein binding on apparent volume of distribution.J. Pharm. Sci. 68:1203–1205 (1975).
J. R. Gillete and J. R. Mitchell.Concepts in Biochemical Pharmacology, Other Aspects of Pharmacology, Springer-Verlag, New York, 1975, pp. 35–85.
J. W. Prothero. Scaling of blood parameters in mammals.Comp. Biochem. Physiol. 67A:649–657 (1980).
K. B. Bishoff, R. L. Dedrick, D. S. Zaharko, and J. A. Longstreth. Methotrexate pharmacokinetics.J. Pharm. Sci. 60:1128–1133 (1971).
J. P. Holt and E. A. Rhode. Similarity of renal glomerular hemodynamics in mammals.Am. Heart. J. 92:465–472 (1976).
A. Tsuji, T. Yoshikawa, K. Nishide, H. Minami, M. Kimura, E. Nakashima, T. Terasaki, E. Miyamoto, C. H. Nightingale, and T. Yamana. Physiologically based pharmacokinetic model forβ-lactam antibiotics I: Tissue distribution and elimination in rats.J. Pharm. Sci. 72:1239–1252 (1983).
K. N. Brown and A. Percival. Penetration of antimicrobials into tissue culture cells and leukocytes.Scand. J. Infect. Dis. Suppl. 14:251–260 (1978).
R. C. Prokesch and W. L. Hand. Antibiotic entry into human polymorphonuclear leukocytes.Antimicrob. Agents Chemother. 21:373–380 (1982).
J. Katz, G. Bonoris, S. Golden, and A. L. Sellers. Extravascular albumin mass and exchange in rat tissues.Clin. Sci. 39:705–724 (1970).
J. J. Fischer and O. Jardetzky. Nuclear magnetic relaxation study of intermolecular complexes. The mechanism of penicillin binding to serum albumin.J. Am. Chem. Soc. 87:3237–3244 (1965).
T. Watanabe, Y. Enjoji, M. Komiya, Kikuchi, R. Kawai, and S. Kawamura. Distribution, excretion and metabolism of14C-cefotetan (14C-YM-09330) in rats.Chemotherapy 30(s-1): 119–136 (1982).
M. Koyama, K. Nakagawa, M. Komiya, Y. Kikuchi, A. Tachibana, and K. Yano. Phase-I clinical study on cefotetan (YM-09330).Chemotherapy 30(s-l):150–162 (1982).
A. Saito, Y. Kato, K. Ishikawa, H. Uemura, M. Tomizawa, I. Nakayama, T. Sakuraba, K. Matsui, and O. Yajima. CS-1170: Pharmacokinetics and clinical evaluation. Chemotherapy26(s-5):145–154 (1978).
H. Matsui, Y. Noshiro, and K. Yano. Pharmacokinetics of cefpiramide (SM-1652), new broadspectrum and long-acting cephalosporin, parentally administered to laboratory animals.Chemotherapy 31(s-l): l14–123 (1983).
H. Yamada, T. Yoshida, T. Oguma, Y. Kimura, Y. Tochino, J. Kurihara, and T. Nagatake. Clinical pharmacology of 6059-S in healthy volunteers.Chemotherapy 28(s-7):251–262 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawada, Y., Hanano, M., Sugiyama, Y. et al. Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animals. Journal of Pharmacokinetics and Biopharmaceutics 12, 241–261 (1984). https://doi.org/10.1007/BF01061720
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061720